Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHB2000778	他达拉非片	tadalafil	Tablet	Chemical Drugs	Supplementary Application	2020-06-12	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	Filed	2020-06-19	view
JYHB2001429	他达拉非片	tadalafil	Tablet	Chemical Drugs	Supplementary Application	2020-08-21	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	Filed	2020-09-01	view
JYHB1901528	他达拉非片	tadalafil	Tablet	Chemical Drugs	Supplementary Application	2019-12-12	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	Filed	2019-12-25	view
JYHB2001432	他达拉非片	tadalafil	Tablet	Chemical Drugs	Supplementary Application	2020-08-21	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	Filed	2020-09-01	view
JYHB2002158	他达拉非片	tadalafil	Tablet	Chemical Drugs(1)	Supplementary Application	2020-10-27	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	Filed	2020-11-09	view
JYHB2000777	他达拉非片	tadalafil	Tablet	Chemical Drugs	Supplementary Application	2020-06-12	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	Filed	2020-06-19	view
JYHB1901527	他达拉非片	tadalafil	Tablet	Chemical Drugs	Supplementary Application	2019-12-12	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	Filed	2019-12-25	view
JYHB2002157	他达拉非片	tadalafil	Tablet	Chemical Drugs	Supplementary Application	2020-10-27	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	Filed	2020-11-16	view
JYHB2000780	他达拉非片	tadalafil	Tablet	Chemical Drugs	Supplementary Application	2020-06-12	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	Filed	2020-06-19	view
JYHB2001431	他达拉非片	tadalafil	Tablet	Chemical Drugs	Supplementary Application	2020-08-21	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	Filed	2020-09-01	view
JYHB2000779	他达拉非片	tadalafil	Tablet	Chemical Drugs	Supplementary Application	2020-06-12	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	Filed	2020-06-19	view
JYHB2001430	他达拉非片	tadalafil	Tablet	Chemical Drugs	Supplementary Application	2020-08-21	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	Filed	2020-09-01	view
JXHL1000225	奥氮平片	olanzapine	Tablet	Chemical Drugs	Import Drug Application	2010-08-09	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	Certificate Issued	2011-12-22	view
JXHL1000227	奥氮平片	olanzapine	Tablet	Chemical Drugs	Import Drug Application	2010-08-09	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	Certificate Issued	2011-12-22	view
JXHL1000226	奥氮平片	olanzapine	Tablet	Chemical Drugs	Import Drug Application	2010-08-09	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	Certificate Issued	2011-12-22	view
JXHS1800010	巴瑞克替尼片	baricitinib	Tablet	Chemical Drugs(5.1)	Import Drug Application	2018-03-12	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	Certificate Issued	2019-07-08	view
JXHS1800009	巴瑞克替尼片	baricitinib	Tablet	Chemical Drugs(5.1)	Import Drug Application	2018-03-12	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	Certificate Issued	2019-07-01	view
JYHB1800264	巴瑞克替尼片	baricitinib	Tablet	Chemical Drugs	Supplementary Application	2018-03-12	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	Certificate Issued	2019-07-01	view
JYHB1800263	巴瑞克替尼片	baricitinib	Tablet	Chemical Drugs	Supplementary Application	2018-03-12	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	Certificate Issued	2019-07-08	view
JYHB2001161	巴瑞替尼片	baricitinib	Tablet	Chemical Drugs	Supplementary Application	2020-07-04	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	Certificate Issued	2020-12-10	view